This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Correlations With Psychotherapeutic Drug Use

E. H. Uhlenhuth, MD; Mitchell B. Balter, PhD; Glen D. Mellinger, PhD; Ira H. Cisin, PhD; Janice Clinthorne, MA

Arch Gen Psychiatry. 1983;40(11):1167-1173.

Abstract
• Using symptom checklists administered on a large scale by survey interviewers in the 1979 National Survey of Psychotherapeutic Drug Use, we developed a method for classifying survey respondents by syndromes. These syndromes had symptoms and other characteristics consistent with their DSM-III diagnostic counterparts and showed one-year prevalence rates in accord with available epidemiologic data: Major Depression, 5.1%; Agoraphobia-Panic, 1.2%; Other Phobia, 2.3%; and Generalized Anxiety, 6.4%. However, the anxietyrelated syndromes occurred less frequently than clinical lore might suggest. The data showed a very low rate of antidepressant use and a higher rate of antianxiety agent use among Major Depressives (11% and 23%) and Agoraphobics (8% and 55%). Also noteworthy were the infrequent use of antianxiety agents among respondents with Generalized Anxiety (27%) and the low frequency of both antianxiety (19%) and antidepressant (3%) drug use among persons with high distress who did not qualify for any syndrome. These findings suggest that the majority of persons with serious psychiatric disorders still do not receive treatment or the most appropriate treatment.

Author Affiliations
From the Department of Psychiatry, The University of Chicago (Dr Uhlenhuth); the Applied Therapeutics and Health Practices Program, National Institute of Mental Health, Bethesda, Md (Dr Balter); the Institute for Research in Social Behavior, Oakland, Calif (Dr Mellinger and Ms Clinthorne); and the Social Research Group, George Washington University, Washington, DC (Dr Cisin).

Footnotes
Accepted for publication June 14, 1983.

Read in part at the annual meeting of the American College of Neuropsychopharmacology, San Diego, Dec 16, 1981.

Reprint requests to Box 411, Department of Psychiatry, The University of Chicago, 950 E 59th St, Chicago, IL 60637 (Dr Uhlenhuth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depression and symptoms affect quality of life in psychogenic nonepileptic seizures
LaFrance and Syc
Neurology 2009;73:366-371.
ABSTRACT | FULL TEXT  

Somatic Symptoms in Late-Life Anxiety: Treatment Issues
Lenze et al.
J Geriatr Psychiatry Neurol 2005;18:89-96.
ABSTRACT  

Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial
Lenze et al.
Am. J. Psychiatry 2005;162:146-150.
ABSTRACT | FULL TEXT  

Longitudinal Study of Psychiatric Symptoms, Disability, Mortality, and Emigration Among Bosnian Refugees
Mollica et al.
JAMA 2001;286:546-554.
ABSTRACT | FULL TEXT  

Disability Associated With Psychiatric Comorbidity and Health Status in Bosnian Refugees Living in Croatia
Mollica et al.
JAMA 1999;282:433-439.
ABSTRACT | FULL TEXT  

Agoraphobia, Simple Phobia, and Social Phobia in the National Comorbidity Survey
Magee et al.
Arch Gen Psychiatry 1996;53:159-168.
ABSTRACT  

Development and Validation of the SDDS-PC Screen for Multiple Mental Disorders in Primary Care
Broadhead et al.
Arch Fam Med 1995;4:211-219.
ABSTRACT  

DSM-III-R Generalized Anxiety Disorder in the National Comorbidity Survey
Wittchen et al.
Arch Gen Psychiatry 1994;51:355-364.
ABSTRACT  

Use of Benzodiazepines in Anxiety Disorders
Shader and Greenblatt
NEJM 1993;328:1398-1405.
FULL TEXT  

Severe Asthma and Depression
Rubin
Arch Fam Med 1993;2:433-440.
ABSTRACT  

Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents
Beers et al.
Arch Intern Med 1991;151:1825-1832.
ABSTRACT  

Multiple Pains and Psychiatric Disturbance: An Epidemiologic Investigation
Dworkin et al.
Arch Gen Psychiatry 1990;47:239-244.
ABSTRACT  

Epidemiological Findings of Seasonal Changes in Mood and Behavior: A Telephone Survey of Montgomery County, Maryland
Kasper et al.
Arch Gen Psychiatry 1989;46:823-833.
ABSTRACT  

Adolescence: What Is Normal?
Offer et al.
Arch Pediatr Adolesc Med 1989;143:731-736.
ABSTRACT  

Prescribing of Psychotropic Medication by Primary Care Physicians and Psychiatrists
Beardsley et al.
Arch Gen Psychiatry 1988;45:1117-1119.
ABSTRACT  

Performance of Screening and Diagnostic Tests: Application of Receiver Operating Characteristic Analysis
Murphy et al.
Arch Gen Psychiatry 1987;44:550-555.
ABSTRACT  

Impact of Severity and Chronicity of Parental Affective Illness on Adaptive Functioning and Psychopathology in Children
Keller et al.
Arch Gen Psychiatry 1986;43:930-937.
ABSTRACT  

Alcohol Abuse, Other Drug Abuse, and Mental Disorders in Medical Practice: Prevalence, Costs, Recognition, and Treatment
Kamerow et al.
JAMA 1986;255:2054-2057.
ABSTRACT  

Adult Sequelae of Adolescent Depressive Symptoms
Kandel and Davies
Arch Gen Psychiatry 1986;43:255-262.
ABSTRACT  

Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders: I. Efficacy in Depressed Outpatients
Lipman et al.
Arch Gen Psychiatry 1986;43:68-77.
ABSTRACT  

Aging and Mental Health: Distinguishing Myth from Reality
Feinson
Research on Aging 1985;7:155-174.
ABSTRACT  

Insomnia and Its Treatment: Prevalence and Correlates
Mellinger et al.
Arch Gen Psychiatry 1985;42:225-232.
ABSTRACT  

Psychiatric Epidemiology Counts
Arch Gen Psychiatry 1984;41:931-933.
ABSTRACT  

Stability of Prevalence: Depression and Anxiety Disorders
Murphy et al.
Arch Gen Psychiatry 1984;41:990-997.
ABSTRACT